Safety and feasibility of biweekly neoadjuvant gemcitabine,...

Safety and feasibility of biweekly neoadjuvant gemcitabine, epirubicin, and albumin bound nab-paclitaxel (GEA) in locally advanced breast cancer – results of a phase II study

D. Daniel, B. Daniel, R. Inhorn, Y. Naot, J. Zubkus, L. Simons, D. Knauer, V. Trieu, N. Desai, D. Yardley
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70557-3
File:
PDF, 74 KB
english, 2008
Conversion to is in progress
Conversion to is failed